The Lead Episode 175: A Discussion of Anticoagulation for AF with Intermediate Stroke Risk-The Lead Episode 175 Speaker Information

The Lead Episode 175 Speaker Information

Pdf Summary

The document introduces a discussion of the New England Journal of Medicine article “Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk,” authored by Daehoon Kim and colleagues.<br /><br />The discussion is hosted by Melissa E. Middeldorp of Adelaide University, with contributors Rachel Schreier of Carilion Clinic and James Freeman of Yale University School of Medicine.<br /><br />Middeldorp and Schreier report no disclosures. Freeman reports speaking or consulting fees from Boston Scientific and Biosense Webster, advisory committee memberships with Medtronic and Pacemate, and research grants through the American College of Cardiology and the National Institutes of Health.

Keywords

Atrial fibrillation

Anticoagulation

Stroke risk

New England Journal of Medicine

Daehoon Kim

Melissa E. Middeldorp

Rachel Schreier

James Freeman

Boston Scientific

Biosense Webster